Drug intelligence / Profile preview

weiruxitong

Development stage: Preclinical
Modality: Transdermal Patches → Device-based Delivery → Drug Delivery Systems, Hydrogel Systems → Drug Delivery Systems
Administration: Topical

Overview

Weiruxitong (also referred to as Weiru Xitong or Weiru Xitong ointment) is a topical preparation used in traditional Chinese medicine. It has been studied as an adjunctive therapy for conditions such as breast hyperplasia and has also appeared in clinical research settings evaluating its effects on immune response, including studies related to COVID-19 vaccine antibody responses. The precise mechanism of action is not well characterized in Western pharmacology, but it is generally considered a non-pharmaceutical herbal or topical remedy rather than a conventional pharmaceutical drug[2][3].

Brand names: weiruxitong
Other names: Weiru Xitong ointmentWeiru Xitong

Beyond the preview

Go deeper on weiruxitong.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on weiruxitong.

Explore the full profile